Value Line (NASDAQ:VALU) reported quarterly earnings of $0.47 per share. This is a 24.19 percent decrease over earnings of $0.62 per share from the same period last year.
Menopause Management: Bayer’s Non-Hormonal Treatment Option Shows Efficacy In Trial
Monday, Bayer AG (OTC: BAYRY (OTC: BAYZF)